Abstract
In the article “Hazard Risk Reductions Should Not Be Communicated as Relative Risk Reductions for Death in Cancer Clinical Trials: Intentional or Inadvertent?” The authors aimed to explore a highly pertinent pitfall in the interpretation of an articl...